This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2014-2015.
Company Filing History:
2 out of 5,383 
2 out of 8,819 
Years Active: 2014-2015
Title: The Innovative Contributions of Christophe Labriere
Introduction
Christophe Labriere is a notable inventor based in Brest, France. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of 2 patents, Labriere's work focuses on the use of indole derivatives for therapeutic purposes.
Latest Patents
Labriere's latest patents include the innovative use of derivatives of indoles for the treatment of cancer. The present invention relates to the use of these derivatives, which have a general formula (I), for the manufacture of a pharmaceutical composition intended for the treatment of cancer. This groundbreaking work aims to provide new avenues for effective cancer therapies.
Career Highlights
Throughout his career, Christophe Labriere has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His experience in these institutions has greatly contributed to his expertise in research and development in the pharmaceutical sector.
Collaborations
Labriere has collaborated with notable colleagues, including Catherine Guillou and Frank Kozielski. These partnerships have fostered a collaborative environment that enhances innovation and research in their respective fields.
Conclusion
Christophe Labriere's contributions to cancer treatment through his innovative use of indole derivatives highlight his importance as an inventor. His work continues to inspire advancements in pharmaceutical research and development.